期刊文献+

磺酰脲类化合物抗肿瘤活性的研究进展 被引量:1

The Development of Anti-Tumor Activity of Sulfonylurea Compounds
暂未订购
导出
摘要 在进一步探讨磺酰脲类化合物除草作用和降糖活性的同时,其抗肿瘤活性早已引起了人们的特别关注。磺酰脲类化合物有可能作为一类新兴的具有前景的抗肿瘤药物应用于医药领域,本文综述了国内外对该类化合物抗肿瘤活性的研究进展,以期对磺酰脲类抗肿瘤化合物的应用发展提供参考。 While the hypoglycemic and herbicidal activity of sulfonylurea is investigated, its anti-tumor ac-tivity has attracted special attention. Sulfonylurea compounds may be used in the medical field as a new class of promising anticancer drugs. In order to provide a reference for the application and development of anti-tumor sulfonylurea compounds, we summarize the domestic and foreign research progress of antitumor activity of the compounds.
出处 《药物化学》 2015年第3期29-37,共9页 Hans Journal of Medicinal Chemistry
  • 相关文献

参考文献4

二级参考文献70

  • 1衣淑珍.磺酰脲类降糖药进展[J].药学情报通讯,1993,11(2):21-24. 被引量:2
  • 2Lubbe A S, Alexiou C, Bercemann C. Clinical application of magnetic drug targeting[J]. J Surgical Res, 2001, 95 (2) : 200.
  • 3Roseanu A, Florian P E, Moisei M, et al. Liposomalization of lactoferrin enhanced its anti-tumoral effects on melanoma cells[J]. Biometals,2010,23(3SD :485.
  • 4Lin Y L, Liu Y K, Tsai N M, et al. A Lipo-PEG-PEI com?plex for encapsulating curcumin that enhances its antitumor effects on curcumin-sensitive and curcumin-resistance cells[J]. Nanomed:Nanotechn,Biology,Med,2012,8(3) :318.
  • 5Iyer A K, Su Y, Feng J J, et al. The effect of internalizing human single chain antibody fragment on liposome targeting to epithelioid and sarcomatoid mesothelioma[J]. Biomate?rials, 2011, 32( 10): 2605.
  • 6Yan Z Q, Wang F, Wen Z v, et a1. Lyl+ l-conjugated PE?Gylated liposomes , A carrier system for targeted therapy of lymphatic metastatic tumor[J]. J Controlled Release, 2012, 157(1):118.
  • 7Takara K, Hatakeyama H, Kibria G, et a1. Size-controlled, dual-ligand modified liposomes that target the tumor vascu?lature show promise for use in drug-resistant cancer therapy[J]. J Controlled Release,2012,162(l):225.
  • 8Yonenaga N, Kenjo E, Asai T, et a1. RGD-based active tar?geting of novel polycation liposomes bearing siRNA for cancer treatment[]]' J Controlled Release, 2012,160 (2): 177.
  • 9Bandekar A, Karve S, Chang M Y, et a1. Antitumor effica?cy following the intracellular and interstitial release of lipo?somal doxorubicin[]]. Biomaterials, 2012,33 (7) : 4345.
  • 10Lehtinen J, Raki M, Bergstrom K A, et a1. Pre-targeting and direct immunotargeting of liposomal drug carriers to ovarian carcinoma[]]. PLOS ONE, 2012,7(7): e41410.

共引文献22

同被引文献7

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部